Is Diethylcarbamazine registered with the SFDA?

The SFDA human drug list (edition 4-2026, as published by the Council of Health Insurance) lists 0 valid registrations of Diethylcarbamazine.

Is Diethylcarbamazine approved by the US FDA?

Drugs@FDA lists 1 application product line for Diethylcarbamazine, including HETRAZAN (Discontinued).

Is Diethylcarbamazine on the WHO Model List of Essential Medicines?

Yes — 6.1.2. Antifilarials (core list): Lymphatic filariasis.

Active substance

Diethylcarbamazine

SFDA 1
US FDA 1
WHO EML 1

Open in the medicines table

SFDA Saudi Arabia — SFDA human drug list

Trade name	Strength	Form · route	Pack	Public price	Type	Company	Status
BANOCIDE 50 MG TAB	50 mg	Tablet · Oral use	100 Blister	SAR 26.10	NCE · Prescription	GLAXOWELLCOME	Withdrawn by MAH · Not Marketed

US FDA United States — FDA approvals (Drugs@FDA)

Product	Strength	Form · route	Applicant	Status	First approved
HETRAZAN	50MG	tablet · oral	LEDERLE	Discontinued	13 Nov 1950

WHO WHO Model List of Essential Medicines (2025)

6.1.2. Antifilarials · core
Lymphatic filariasis
Oral > Solid: 50 mg tablet (dihydrogen citrate); 100 mg tablet (dihydrogen citrate)

Values as published by each source: SFDA human drug list (4-2026, as published by the Council of Health Insurance; indications from the CHI Daman Drug Formulary), Drugs@FDA, EMA medicines data, Health Canada Drug Product Database (Open Government Licence – Canada), CMS NADAC, NHS Drug Tariff Part VIIIA (NHSBSA Copyright, Open Government Licence v3.0), WHO Model List of Essential Medicines (CC BY 3.0 IGO; regrouped by active substance, not created by WHO), EMA PRAC, US FDA safety-related labeling changes and MHRA Drug Safety Update (Open Government Licence v3.0). Sources and reuse. Not a substitute for the official registers or the product information.